REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/05/2026
Voltar para busca
Dado oficial do USPTO
IMMUNOVIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
IMMUNOVIA
ST13
US500000079176585Classe
5, 9, 10, 42, 44
Pedido
79176585
Registro
5197689
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
10/05/2026
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
25/08/2015
Data de registro
09/05/2017
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/01/2024
Última transação
10/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Lund, SE
Examinador
PEETE, KYLE C
Unidade examinadora
M30
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Immunovia AB
Immunovia AB
Representantes
Anuj Desai Arnall Golden Gregory LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Sanitary preparations for medical use; biological indicators for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes for the diagnosis of cancer and auto-immune diseases
Classe 9
Computer software for diagnosis of disease; computer software for diagnosing of cancer diseases; computer software for diagnosing of pancreatic cancer; computer software for diagnosing of breast cancer; computer software for diagnosing of prostate cancer; computer software for diagnosing of auto-immune diseases; DNA chips
Classe 10
Medical apparatus and instruments for diagnosticprognostic patient stratificationexamination and monitoring purposesapparatus for multiplex measuring of proteins in blood; diagnostic apparatus for medical purposes for diagnosing cancer and auto-immune diseases; sensor apparatus for medical use in diagnosis for diagnosing cancer and auto-immune diseases; apparatus for carrying-out diagnostic tests for medical purposes for diagnosing cancer and auto-immune diseases; medical diagnostic apparatus for detecting cancer and auto-immune diseases; DNA microarray for use in medical research for medical purposes for the diagnosis of cancer and auto-immune diseases; blood testing analyzers for medical purposes for the diagnosis of cancer and auto-immune diseases
Classe 42
Medical research services; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the area of pancreatic cancerous diseases; scientific research for medical purposes in the area of breast cancerous diseases; scientific research for medical purposes in the area of prostate cancerous diseases; scientific research for medical purposes in the area of auto-immune diseases; providing computer aided medical testing servicescomputer aided blood analysis services in the field of cancer and auto-immune diseases research; research and development of computer software
Classe 44
Performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; performing diagnosis of cancer and auto-immune diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/12/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
18/09/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/05/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/02/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/01/2024
71AG
REGISTERED-SEC.71 ACCEPTED
04/01/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/01/2024
ES71
TEAS SECTION 71 RECEIVED
04/05/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/05/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/08/2017
FIMP
FINAL DISPOSITION PROCESSED
11/08/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
09/05/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/05/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/04/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/02/2017
PUBO
PUBLISHED FOR OPPOSITION
21/02/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/01/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
16/01/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/01/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
16/01/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/01/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/07/2016
GNFR
FINAL REFUSAL E-MAILED
16/07/2016
CNFR
FINAL REFUSAL WRITTEN
16/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/06/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/06/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/06/2016
RFNP
REFUSAL PROCESSED BY IB
04/01/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/12/2015
RFRR
REFUSAL PROCESSED BY MPU
15/12/2015
MAFR
APPLICATION FILING RECEIPT MAILED
15/12/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/12/2015
CNRT
NON-FINAL ACTION WRITTEN
11/12/2015
DOCK
ASSIGNED TO EXAMINER
10/12/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/12/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/12/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IMMUNOVIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.